In a 64-year-old woman with ferritin 306 ng/mL, hemoglobin 12.9 g/dL, serum iron 54 µg/dL, TIBC 250 µg/dL, iron saturation 22 % while taking ferrous sulfate (325 mg) daily, and an isolated serum chloride of 107 mmol/L, should I stop the iron supplement and how should I address the elevated chloride?

Stop Iron Supplementation Immediately

You should discontinue the ferrous sulfate 325 mg daily in this patient, as she has no evidence of iron deficiency and her ferritin is elevated at 306 ng/mL with adequate iron stores. 1

Iron Status Assessment

Your patient's iron panel demonstrates:

• Ferritin 306 ng/mL - elevated and indicating adequate iron stores
• Iron saturation 22% - borderline adequate (>20% threshold)
• Hemoglobin 12.9 g/dL - normal, no anemia present
• TIBC 250 µg/dL - normal range

Why Stop Iron Supplementation?

The evidence is clear that higher ferritin and transferrin saturation levels indicate lower likelihood of iron deficiency 1. In the general population without chronic kidney disease or erythropoietin therapy, ferritin >100 ng/mL typically indicates adequate iron stores 1. Your patient's ferritin of 306 ng/mL is well above this threshold.

Key principle: Ferritin is an acute phase reactant and can be falsely elevated with inflammation 1, but in the absence of clinical signs of inflammation and with normal hemoglobin, this ferritin level most likely reflects true iron stores rather than inflammation.

Clinical Action Plan for Iron

1. Immediately discontinue ferrous sulfate - there is no indication for supplementation
2. Verify the original indication - determine why iron was started (was there prior anemia or documented deficiency?)
3. Repeat iron panel in 3 months including:
   • Ferritin
   • Iron saturation
   • Hemoglobin
   • TIBC

Important Caveat

If the patient has a history of iron deficiency anemia that was being treated, the current labs suggest treatment has been successful and continuation risks iron overload. Even in conditions requiring iron supplementation (like chronic kidney disease on erythropoietin), guidelines recommend maintaining ferritin >100 ng/mL with no specific upper limit set, though functional monitoring is important 1.

Chloride Elevation: No Action Needed

The isolated chloride of 107 mmol/L requires monitoring only, not active intervention.

Why No Immediate Action?

• Minimal elevation: 107 mmol/L is only slightly above the typical upper limit of normal (usually 106 mmol/L)
• Isolated finding: All other electrolytes, renal function, and hepatic function are stable
• No clinical context: No acidosis, no symptoms, no other metabolic derangements

Differential Considerations for Mild Hyperchloremia

While not requiring immediate treatment, consider these potential causes:

• Laboratory variation - most likely given minimal elevation
• Dehydration - though other markers are normal
• Metabolic acidosis - check anion gap if concerned (appears normal given stable CMP)
• Medications - review for acetazolamide, topiramate, or other carbonic anhydrase inhibitors
• Renal tubular acidosis - unlikely with normal renal function and no other findings

Monitoring Plan for Chloride

1. Repeat basic metabolic panel in 3 months when rechecking iron studies
2. Calculate anion gap if chloride remains elevated or increases
3. Assess for symptoms of metabolic acidosis (fatigue, confusion, rapid breathing) - though none are present
4. No dietary modifications needed for this minimal elevation

When to Escalate Chloride Concern

Act if you see:

• Chloride >110 mmol/L
• Development of low bicarbonate (metabolic acidosis)
• Rising creatinine or declining GFR
• New symptoms (weakness, confusion, polyuria)
• Widening or narrowing of anion gap

The trace ketones and calcium oxalate crystals on urinalysis are likely related to hydration status and dietary factors, not the mild chloride elevation. Your recommendation for adequate hydration is appropriate.